![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/397 | |
A61K 31/4704 | |||
A61P 37/00 |
(11) | Number of the document | 3206682 |
(13) | Kind of document | T |
(96) | European patent application number | 15784974.6 |
Date of filing the European patent application | 2015-10-14 | |
(97) | Date of publication of the European application | 2017-08-23 |
(45) | Date of publication and mention of the grant of the patent | 2018-09-26 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/IB2015/057870 |
Date | 2015-10-14 |
(87) | Number | WO 2016/059571 |
Date | 2016-04-21 |
(30) | Number | Date | Country code |
201462064537 P | 2014-10-16 | US |
(72) |
SMITH, Paul Alfred, CH
|
(73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
(54) | COMBINATIONS COMPRISING SIPONIMOD AND LAQUINIMOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS |
COMBINATIONS COMPRISING SIPONIMOD AND LAQUINIMOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS |